Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

The shift towards glucose-sensing technology has heralded a new era in diabetes management, moving from occasional, reactive ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

In this device, they help refine glucose measurements by identifying patterns, enhancing accuracy through continuous adaptation. Non-invasive monitoring refers to health assessment techniques that do ...

The device is similar to Abbott’s FreeStyle Libre, which people with diabetes ... A number of studies show that continuous glucose monitors have potential benefits for people without diabetes ...

patients need to regularly monitor their blood glucose levels (BGLs) to manage the disease. While traditional BGL-measuring devices have relied on painful finger pricks for decades, advancements ...

is thrilled to announce a new data integration with continuous glucose monitoring (CGM) manufacturer Abbott (NYSE: ABT). A ...

Wearable electronic devices are potential tools to monitor blood glucose levels (BGLs) among people with diabetes, but their limited size and power lead to noticeable measurement errors.